More News
19 February 2013
Galectin Therapeutics Announces Discovery Program for New Anti-Galectin Drugs in Collaboration with the University of Georgia18 February 2013
AbCheck Antibody Discovery Agreement with U3 Pharma18 February 2013
Roche and Chiasma announce collaboration to develop and commercialize Chiasma’s Octreolin for acromegaly and neuroendocrine tumors14 February 2013
Mylan Enhances Partnership with Biocon through Strategic Collaboration for Insulin Products13 February 2013
MorphoSys and Heptares Sign Alliance to Develop Antibody Therapeutics Targeting GPCRs12 February 2013
Lycera Enters Into a Collaboration Agreement with Merck12 February 2013
RQx Pharmaceuticals and Genentech Enter Drug Discovery Collaboration to Develop Novel Drug Compounds11 February 2013
AMRI Signs Agreement for Exclusive License of its Tubulin Inhibitor Program for Cancer9 February 2013
Shire Regenerative Medicine Initiates Phase 3 Study of ABH001 for Patients with Epidermolysis Bullosa7 February 2013
Argenta and ANTABIO Announce Drug Discovery Collaboration4 February 2013
Aduro Announces Acquisition of GVAX Assets From BioSante4 February 2013
Stem Cell Therapeutics Announces Agreement With Trillium Therapeutics Inc. for Merger30 January 2013
4-Antibody AG and the Ludwig Institute Expand Oncology Antibody R&D Program with Three New Targets29 January 2013
Merck Serono and Feinstein Institute to Partner on Pre-clinical Program in Inflammatory Diseases29 January 2013
Afraxis Grants Exclusive Global License to Genentech28 January 2013
Immunomedics in Collaboration With Algeta to Evaluate Potential of Epratuzumab Conjugated to Alpha-Emitter Thorium-22727 January 2013
Kineta Adds to Its Pipeline of Venom-Derived Drug Candidates, In-licenses Conotoxin Program for Non-Narcotic Pain Relief24 January 2013
Baxter Announces Agreement to Acquire Investigational Hemophilia Compound OBI-1 and Related Assets23 January 2013
Watson Acquires Uteron Pharma SANews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports